Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors

by Weiping Li, Shiv K. Gupta, Weiguo Han, Ryan A. Kundson, Sara Nelson, Darlene Knutson, Patricia T. Greipp, Sherine F. Elsawa, Eduardo M. Sotomayor, Mamta Gupta
Published 2019-07-01

Hepatic YAP1-TFE3 Rearranged Epithelioid Hemangioendothelioma

by Mira M. Lotfalla, Andrew L. Folpe, Karen J. Fritchie, Patricia T. Greipp, Gretchen G. Galliano, Kevin C. Halling, Taofic Mounajjed, Jorge Torres-Mora, Rondell P. Graham
Published 2019-01-01

Myeloid malignancies with 5q and 7q deletions are associated with extreme genomic complexity, biallelic TP53 variants, and very poor prognosis

by Beth A. Pitel, Neeraj Sharma, Cinthya Zepeda-Mendoza, James B. Smadbeck, Kathryn E. Pearce, Joselle M. Cook, George Vasmatzis, Zohar Sachs, Rashmi Kanagal-Shamanna, David Viswanatha, Sheng Xiao, Robert B. Jenkins, Xinjie Xu, Nicole L. Hoppman, Rhett P. Ketterling, Jess F. Peterson, Patricia T. Greipp, Linda B. Baughn
Published 2021-02-01

Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH‐based algorithm distinguishes prognostic groups and outcomes

by Zaid H. Abdel-Rahman, Michael G. Heckman, Theodora Anagnostou, Launia J. White, Sara M. Kloft‐Nelson, Ryan A. Knudson, Hassan B. Alkhateeb, Lisa Z. Sproat, Nandita Khera, Hemant S. Murthy, Ernesto Ayala, William J. Hogan, Vivek Roy, Jess F. Peterson, Mohamed A. Kharfan-Dabaja, Rhett P. Ketterling, Mark R. Litzow, Linda B. Baughn, Mrinal Patnaik, Patricia T. Greipp, James M. Foran
Published 2021-09-01